{"version":"1.0","type":"link","title":"First-in-human results of terbium-161 [Tb]Tb-PSMA-I&T dual beta-Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 study.","author_name":"Buteau JP 외","author_url":"https://prs-insight.online/author/Buteau%20JP","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/137362","thumbnail_width":1200,"thumbnail_height":630}